Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • ADVERTISEMENT FEATURE Advertiser retains sole responsibility for the content of this article

When liver disease patients fall off the medical radar

The hepatitis B virus can be fatal if left untreated.SCIENCE PICTURE CO / ALAMY STOCK PHOTO

Just under a third of hepatitis patients surveyed at King Abdulaziz Medical City in Riyadh did not attend afollow-up appointment with the hospital. More than two-thirds of those weren’t aware an appointment had beenscheduled. Researchers urge better information, education and communication to help reduce the incidence of liver disease complications.

Minimising the number of patients who become unreachable — known in the medical field as ‘lost to follow-up’— during treatment programmes is critical. For peoplewith hepatitis, insufficient care can lead to seriouscomplications such as liver scarring (cirrhosis), failure and cancer.

Close to 400 million people are affected by the hepatitisB virus (HBV) and another 170 million are living with hepatitis C virus (HCV) around the world. In Saudi Arabia, despite a large-scale HBV vaccination initiative launched in 1989, theincidence of both types of the disease remains higher than expected.

To gain a better idea of the number of hepatitis patients who drop out of treatment, and to reveal the reasons behind the lack of follow-up, a multi-institutional team surveyed people diagnosed with HBV and HCV between 2009 and 2010 at King Abdulaziz Medical City (KAMC) in Riyadh.

The team was led by Hanan Balkhy, chairman of KAIMRC’s infectious disease section and executive director of the Infection Prevention and Control Program at the Ministry of National Guard– Health Affairs (NGHA).

Of a total of 328 patients who completed the telephone survey, 98 (around 30%) were deemed lost to follow-up. Ofthose 98, the top reason given (by 69% of respondents) for not returning for treatment was that they were unaware that afollow-up appointment was scheduled. Other reasons given were that they were never informed about the need for follow-up (15%) or they had a personal belief that follow-up was not necessary (9%).

The number of patients lost to follow-up was found to be higher among those diagnosed with HBV (71.4%) compared with HCV (28.6%). As yet, the full extent of the problem nationwide is unknown. Since the study was conductedat just one large NGHA-affiliated hospital, the researchers point out that “the reported 30% may underestimate the magnitude of the problem at primary care centres and at the community level, where many people have never been diagnosed or referred.”

If left undiagnosed or untreated, the burden of liver disease on hospitals and families will continue to increase and lead to a greater number of people requiring transplants.

The study calls for a greater focus on education, as well as more efficient and flexible referral and scheduling systems.A dedicated health centre for hepatitis patients may help achieve this goal. The team suggests that sending reminders to patients via text messaging and email will also be important.

References

  1. Balkhy, H. H. et al. Journal of Infection and Public Health 10, 379—387 (2017).

    Article  PubMed  Google Scholar 

Download references

Search

Quick links